Consumer goods group Reckitt Benckiser has reported a strong start to 2013 after a heavy flu and colds season boosted demand for Strepsils and Nurofen.
The Slough-based group, which owns brands including Harpic, Dettol and Durex, also made big strides in its rapidly-expanding markets of India, Brazil and China, driving 6% underlying revenues growth during the first three months of the year.
Total revenues improved 7% to £2.5bn and Reckitt said it is confident of achieving 5-6% growth for the year.
Reckitt benefited from a spate of flu and colds in the US, with successful launches of new products such as Strepsils lozenges and Nurofen heat patches.
Other innovations such as Mucinex Fast Max and Sinus Max decongestants drove growth in the US, helping its European and North American division increase underlying sales 3% amid sluggish consumer spending.